Public awareness about the link between human papillomavirus, or HPV, and cancer is low. A doctor explains why its lifesaving ...

An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...

A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...

IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

A one-size-fits-all vaccine has shown promising results in keeping hard-to-treat pancreatic cancers from coming back. The ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

In May, Ira Mellman, Genentech's vice president of cancer immunology, and his collaborators published a study in the journal Nature detailing the effect of their vaccine on 16 people with one of ...